Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 24895-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- PTGER4 antibody
- Antibody type
- Polyclonal
- Description
- PTGER4 antibody (Cat. #24895-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Prostaglandin E2 accelerated recovery of chemotherapy-induced intestinal damage by increasing expression of cyclin D.
Endothelial cell prostaglandin E2 receptor EP4 is essential for blood pressure homeostasis.
Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects.
Inhibition of prostaglandin E2 receptor 4 by lnc000908 to promote the endothelial-mesenchymal transition participation in cardiac remodelling.
Antibiotic pretreatment alleviates liver transplant damage in mice and humans.
Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway.
Yue M, Shao L, Cheng J, Fan Y, Cai X, Li H, Li M, Zhang X, Fu A, Huang Y, Nie C, Long F, Chen H, Zhu Q, Zeng H
Experimental cell research 2020 Mar 15;388(2):111819
Experimental cell research 2020 Mar 15;388(2):111819
Endothelial cell prostaglandin E2 receptor EP4 is essential for blood pressure homeostasis.
Xu H, Fang B, Du S, Wang S, Li Q, Jia X, Bao C, Ye L, Sui X, Qian L, Luan Z, Yang G, Zheng F, Wang N, Chen L, Zhang X, Guan Y
JCI insight 2020 Jul 9;5(13)
JCI insight 2020 Jul 9;5(13)
Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects.
Vianello E, Dozio E, Bandera F, Froldi M, Micaglio E, Lamont J, Tacchini L, Schmitz G, Corsi Romanelli MM
International journal of molecular sciences 2020 Jan 14;21(2)
International journal of molecular sciences 2020 Jan 14;21(2)
Inhibition of prostaglandin E2 receptor 4 by lnc000908 to promote the endothelial-mesenchymal transition participation in cardiac remodelling.
Chen X, Ge W, Hu J, Dong T, Yao H, Chen L, Geng B, Zhou H
Journal of cellular and molecular medicine 2019 Sep;23(9):6355-6367
Journal of cellular and molecular medicine 2019 Sep;23(9):6355-6367
Antibiotic pretreatment alleviates liver transplant damage in mice and humans.
Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, Dery KJ, Everly MJ, Taura K, Uemoto S, Farmer DG, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW
The Journal of clinical investigation 2019 Jul 22;129(8):3420-3434
The Journal of clinical investigation 2019 Jul 22;129(8):3420-3434
Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway.
Li H, Luo Y, Xu Y, Yang L, Hu C, Chen Q, Yang Y, Ma J, Zhang J, Xia H, Li Y, Yang J
Molecular pharmaceutics 2018 Sep 4;15(9):4121-4131
Molecular pharmaceutics 2018 Sep 4;15(9):4121-4131
No comments: Submit comment
No validations: Submit validation data